Friday, March 13, 2020 5:07:12 PM
I just received corroboration from Mark about the Covid-19 effort:
Re: Test for SARS-CoV-2 (COVID-19)
Fri, Mar 13 2020 2:40 PMFrom:"Mark Schena" <mark@arrayit.com>
To:
xxxxxxxx@charter.net
Priority:Normal
Attachments (1) arrayit logo.jpg Print
Dear xxx, Confirming that we have a SARS-CoV-2 (COVID-19) test and that the test has been submitted for emergency approval. Thanks, Mark
On Mar 13, 2020, at 12:38 PM,xxxxxxxx@charter.net wrote:
Mark,
I appreciate the demands on your time during the pandemic, but I'd appreciate your feedback regarding Arrayit's involvement with Covid-19 testing. Some investors have reported that you have e-mailed them confirming that subject test has been developed and subsequently submitted for emergency approval by the appropriate federal agencies.
Can you corroborate that Arrayit has developed the SARS-COV-2 (COVID-19) test and that is is being considered for emergency approval?
Thank you for your time.
Best regards,
xxxxxx
Dr. Mark Schena, Ph.D.
President
Arrayit Corporation (ARYC)
927 Thompson Place
Sunnyvale, CA 94085
USA
Phone 408-744-1331
Fax 408-744-1711
Mobile 650-248-8710
Email mark@arrayit.com
Web http://arrayit.com
Notice of content filtering and monitoring: Arrayit Corporation and its subsidiaries and business units (collectively, “Arrayit” and “the Company”) reserve the right to monitor, filter and archive all e-mail communications sent and/or received by its employees. Arrayit is not responsible for any typographical error and any pricing or offers contained in this e-mail are subject to change without notice. Notice of proprietary and/or material information: This e-mail and any of its attachments may contain proprietary and/or material information that may be deemed privileged, confidential or subject to copyright belonging to Arrayit. This e-mail is intended solely for the use of the individual or entity to which it is addressed. If you are not the intended recipient of this e-mail, you are hereby notified that any dissemination, distribution, copying, or action taken in relation to the contents of and attachments to this e-mail is strictly prohibited and may be unlawful. If you have received this e-mail in error, please notify the Sender immediately by telephone at 408-744-1331, and permanently delete the original and any copy or printout. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements that are not historical facts contained in this email may include forward-looking statements that involve certain risks and uncertainties detailed in the Company’s filings with the Securities and Exchange Commission. For information provided by Arrayit with respect to its business and business prospects, as well as the risks associated with an investment in our Company’s publicly traded securities, please see the Company’s reports filed with the U.S. Securities and Exchange Commission, copies of which are available at www.sec.gov and also on the Company website, found at www.arrayit.com.
Re: Test for SARS-CoV-2 (COVID-19)
Fri, Mar 13 2020 2:40 PMFrom:"Mark Schena" <mark@arrayit.com>
To:
xxxxxxxx@charter.net
Priority:Normal
Attachments (1) arrayit logo.jpg Print
Dear xxx, Confirming that we have a SARS-CoV-2 (COVID-19) test and that the test has been submitted for emergency approval. Thanks, Mark
On Mar 13, 2020, at 12:38 PM,xxxxxxxx@charter.net wrote:
Mark,
I appreciate the demands on your time during the pandemic, but I'd appreciate your feedback regarding Arrayit's involvement with Covid-19 testing. Some investors have reported that you have e-mailed them confirming that subject test has been developed and subsequently submitted for emergency approval by the appropriate federal agencies.
Can you corroborate that Arrayit has developed the SARS-COV-2 (COVID-19) test and that is is being considered for emergency approval?
Thank you for your time.
Best regards,
xxxxxx
Dr. Mark Schena, Ph.D.
President
Arrayit Corporation (ARYC)
927 Thompson Place
Sunnyvale, CA 94085
USA
Phone 408-744-1331
Fax 408-744-1711
Mobile 650-248-8710
Email mark@arrayit.com
Web http://arrayit.com
Notice of content filtering and monitoring: Arrayit Corporation and its subsidiaries and business units (collectively, “Arrayit” and “the Company”) reserve the right to monitor, filter and archive all e-mail communications sent and/or received by its employees. Arrayit is not responsible for any typographical error and any pricing or offers contained in this e-mail are subject to change without notice. Notice of proprietary and/or material information: This e-mail and any of its attachments may contain proprietary and/or material information that may be deemed privileged, confidential or subject to copyright belonging to Arrayit. This e-mail is intended solely for the use of the individual or entity to which it is addressed. If you are not the intended recipient of this e-mail, you are hereby notified that any dissemination, distribution, copying, or action taken in relation to the contents of and attachments to this e-mail is strictly prohibited and may be unlawful. If you have received this e-mail in error, please notify the Sender immediately by telephone at 408-744-1331, and permanently delete the original and any copy or printout. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements that are not historical facts contained in this email may include forward-looking statements that involve certain risks and uncertainties detailed in the Company’s filings with the Securities and Exchange Commission. For information provided by Arrayit with respect to its business and business prospects, as well as the risks associated with an investment in our Company’s publicly traded securities, please see the Company’s reports filed with the U.S. Securities and Exchange Commission, copies of which are available at www.sec.gov and also on the Company website, found at www.arrayit.com.
